Malignant carcinoid: effect of parenteral methotrexate (NSC-740) therapy alone and in combination with cyclophosphamide (NSC-26271) orally.
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged
D003520:Cyclophosphamide; D008727:Methotrexate